Remove 2023 Remove Digital Health Remove Drug Development Remove Patient Experience
article thumbnail

How Digital Health improves patient experiences in Alzheimer’s care

Digital Health Global

Alzheimer’s disease will affect 13 million Americans by 2050 , up from 6 million in 2023. Also, the financial burden in the United States is tremendous, expected to exceed $345 billion in 2023 and surpass $1 trillion by 2050.

article thumbnail

Medable Partners with Duke BASE Lab to Study Patient Preference of Electronic Informed Consent in Clinical Trials

Digital Health Global

In a large, bi-annual survey on patient experiences with clinical research, use of electronic consent forms (on an iPad, tablet, or other device) increased from 24% in 2019 to 44% in 2021, dipping slightly in 2023 to 32%. Medable, which ranked in the top 8% of software companies on the 2023 Inc. 5000 in 2023.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

Lloyd Price

Its ability to synchronise monitoring of patients at home or at local clinics and to provide diagnostic, treatment and clinical trials intelligence can be transformative. It stated: ‘By 2025, global spend on digital health is predicted to reach €1tn and digital products and services will grow to a market share of 12% (Choueiri et al.,

article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. It enables the delivery of traditional, hybrid and decentralised clinical trials while enhancing the patient experience.